Drug Type Exosomes |
Synonyms ILB 332, ILB332 |
Target |
Action inhibitors |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chorioamnionitis | Preclinical | South Korea | 01 Nov 2024 | |
Obstetric Labor, Premature | Preclinical | United States | 22 Jan 2021 | |
Obstetric Labor, Premature | Preclinical | United States | 22 Jan 2021 | |
Obstetric Labor, Premature | Preclinical | South Korea | 22 Jan 2021 |